Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OM SAI PHARMA PACK

Home Clinical Trial Sponsors and OrganizationsOM SAI PHARMA PACK

OM SAI PHARMA PACK

173, Phase-1, Udyog Vihar, Gurugram, Haryana, India

Also known as:

ospp

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

6

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

3

50.0%

Not Applicable

1

16.7%

Trial Status Distribution

Completed

5

83.3%

Not yet recruiting

1

16.7%

Clinical Trials

Trials sponsored by this organization (6)

To study the safety of the test product after applying it on skin in men and women.

Jan 202652 participants

A clinical study to assess the efficacy and safety of Clascoterone Cream in patients with pimples.

Not yet recruiting

Aug 2025228 participants

To evaluate safety of a test product for skin irritation

Mar 202160 participants

A Clinical Study to Compare the Efficacy and Safety of Ozenoxacin Cream 1% w/w in patients with Secondarily Infected Traumatic Skin Lesions

Jan 2020200 participants

A Clinical Study to Compare the Efficacy and Safety of Ozenoxacin Cream 1% w/w in patients with Secondarily Infected Traumatic Skin Lesions

204 participants

To evaluate safety of a test product for skin irritatio

56 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials6
Approvals
News

Back to Organizations